sb 203580 has been researched along with ym 201636 in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (ym 201636) | Trials (ym 201636) | Recent Studies (post-2010) (ym 201636) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 37 | 0 | 33 |
| Protein | Taxonomy | sb 203580 (IC50) | ym 201636 (IC50) |
|---|---|---|---|
| 1-phosphatidylinositol 3-phosphate 5-kinase | Homo sapiens (human) | 0.0412 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caballero, E; García-Cárceles, J; Gil, C; Martínez, A | 1 |
1 review(s) available for sb 203580 and ym 201636
| Article | Year |
|---|---|
Kinase Inhibitors as Underexplored Antiviral Agents.
Topics: Animals; Antiviral Agents; Drug Repositioning; Humans; Protein Kinase Inhibitors; Virus Diseases; Viruses | 2022 |